ESG (Environmental, Social and Governance) Survey on Pharmaceutical Manufacturing – Towards a Sustainable Supply Chain

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Sustainability referred to as environmental, social, and governance (ESG), is gaining prominence and is likely to continue doing so in the coming years. Social inequality, corruption, tax avoidance, and a lack of action on climate change are all issues that companies must now address head-on, in full public view.

This ESG survey on pharmaceutical manufacturing report examines the pharmaceutical supply chain through the lens of ESG: In what ways does pharmaceutical manufacturing impact the society? How sustainable are its current practices? With what goals and methods can the industry improve its sustainability?

GlobalData ESG Framework

GlobalData ESG Framework

For more insights on ESG framework, download a free report sample

ESG Survey on Pharmaceutical Manufacturing - Poll Questions

GlobalData ran six polls on its Verdict network of B2B websites:

Q1: What is the most important sustainability area that the pharma industry needs to address?

Q2: Do you think that the pharma industry is doing enough to be more environmentally sustainable?

Q3: What is the main challenge to pharmaceutical companies achieving sustainable manufacturing?

Q4: How can the pharmaceutical industry best reduce its damage to the environment (end-of-pipe actions)?

Q5: How can the pharmaceutical industry best reduce its damage to the environment (pre-/post-manufacturing actions)?

Q6: What factors can motivate the pharma industry to improve its environmental, social, and governance actions?

ESG on Pharmaceutical Manufacturing – Key Findings

In the GlobalData survey, environmental sustainability is the top priority for respondents. Thus, pharma manufacturing must be made more environmentally sustainable. The supply chains might also be made more secure through onshoring, manufacturer diversification, and stockpiling.

To know more about key survey findings on ESG in pharmaceutical manufacturing, download a free report sample

ESG on Pharmaceutical Manufacturing – Challenges and solutions

The key challenges to pharmaceutical manufacturing are lack of investment in expertise/technology, lack of buy-in from management/key stakeholders, not identifying environmental impacts of products early enough in their lifecycle, and others. According to the GlobalData pharmaceutical manufacturing, ESG survey lack of investment in expertise/technology is the main challenge.

The pharmaceutical industry can best reduce its damage to the environment (end-of-pipe actions) by reducing carbon emissions and overall energy consumption.

 To know more about challenges and solutions in ESG in pharmaceutical manufacturing, download a free report sample

Market Overview

Key Challenges Lack of Investment in Expertise/Technology, Lack of Buy-In From Management/Key Stakeholders, Not Identifying Environmental Impacts of Products Early Enough in their Lifecycle, and Others
Key Solutions Reducing Carbon Emissions and Overall Energy Consumption
Key Sustainability Area Environment

Scope

This page report gives important, expert insight you won’t find in any other source. 23 figures and graphics throughout the report illustrate major points and trends. This report is required reading for:

  • CMO executives and strategic decision-makers: improve understanding of the pharma manufacturing industry and is a critical input for strategic ESG planning efforts.
  • Sourcing and procurement executives in bio/pharmaceutical companies: improving understanding of crucial components of the supply base that will provide insights for supplier selection and management.
  • Investors: they can gain a deeper understanding of the pharma manufacturing industry and the forces driving change.

Reasons to Buy

ESG should not be an exercise in corporate “greenwashing”, and this report is a realistic look at the pharma industry’s actions and values. We assess the industry’s will to change, and pragmatic motivations that can influence company behavior.

Table of Contents

Executive Summary

Objectives, Design & Methodology

Our ESG Framework

Ranking Sustainability Priorities

Environmental Sustainability: Is the Pharma Industry Doing Enough?

Challenges and Solutions

Social Sustainability: Shortages & Strong Supply Chains

Implementing Change

Appendix

Abbreviations

Related Reports

About the Authors

Our thematic research methodology

Frequently asked questions

ESG (Environmental, Social and Governance) Survey on Pharmaceutical Manufacturing – Towards a Sustainable Supply Chain thematic reports
Currency USD
$4,995

Can be used by individual purchaser only

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

ESG (Environmental, Social and Governance) Survey on Pharmaceutical Manufacturing – Towards a Sustainable Supply Chain was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at ESG (Environmental, Social and Governance) Survey on Pharmaceutical Manufacturing – Towards a Sustainable Supply Chain in real time.

  • Access a live ESG (Environmental, Social and Governance) Survey on Pharmaceutical Manufacturing – Towards a Sustainable Supply Chain dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.